138 related articles for article (PubMed ID: 12242653)
1. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
2. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
3. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
4. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
5. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas.
Jonkers J; Korswagen HC; Acton D; Breuer M; Berns A
EMBO J; 1997 Feb; 16(3):441-50. PubMed ID: 9034327
[TBL] [Abstract][Full Text] [Related]
6. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
7. Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only.
Martín-Hernández J; Sørensen AB; Pedersen FS
J Virol; 2001 Dec; 75(23):11907-12. PubMed ID: 11689675
[TBL] [Abstract][Full Text] [Related]
8. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
9. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
10. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
11. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
[TBL] [Abstract][Full Text] [Related]
12. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
[TBL] [Abstract][Full Text] [Related]
14. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
15. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
16. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
17. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
18. Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.
Rasmussen MH; Sørensen AB; Morris DW; Dutra JC; Engelhard EK; Wang CL; Schmidt J; Pedersen FS
Virology; 2005 Jul; 337(2):353-64. PubMed ID: 15913695
[TBL] [Abstract][Full Text] [Related]
19. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
[TBL] [Abstract][Full Text] [Related]
20. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination.
Quong MW; Harris DP; Swain SL; Murre C
EMBO J; 1999 Nov; 18(22):6307-18. PubMed ID: 10562543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]